Next Article in Journal
6-Amino-7-((4-methoxybenzyl)thio)quinazolin-4(3H)-one
Previous Article in Journal
3-(4-Ferrocenyl-1H-1,2,3-triazol-1-yl)cholic Acid
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Short Note

5-Bromo-N′-(2-oxoindolin-3-ylidene)furan-2-carbohydrazide

1
Department of Chemistry, Faculty of Science and Analytical Data, Institut Teknologi Sepuluh Nopember, Kampus ITS Sukolilo, Surabaya 60111, Indonesia
2
Research Center for Pharmaceutical Ingredient and Traditional Medicine, National Research and Innovation Agency (BRIN), Cibinong Science Center, Bogor 16915, Indonesia
*
Author to whom correspondence should be addressed.
Molbank 2024, 2024(4), M1941; https://doi.org/10.3390/M1941
Submission received: 31 October 2024 / Revised: 17 December 2024 / Accepted: 17 December 2024 / Published: 19 December 2024
(This article belongs to the Section Organic Synthesis and Biosynthesis)

Abstract

:
5-Bromo-N′-(2-oxoindolin-3-ylidene)furan-2-carbohydrazide (1) was successfully synthesized in 79.4% yield by reaction of isatin with 5-bromofuran-2-carbohydrazide in acidic conditions under reflux. The structure of synthesized compound 1 was confirmed by 1H and 13C NMR, FTIR, and HRMS spectrometers. It is necessary to evaluate compound 1 as an anti-inflammatory agent.

1. Introduction

Inflammation is the immune system’s response to harm and is an essential defense mechanism for health [1]. Notwithstanding, uncontrollable inflammation in different parts of the body contributes to the pathogenesis of numerous chronic diseases, including diabetes, neurodegenerative diseases like Alzheimer’s, and cardiovascular diseases like atherosclerosis [2]. Thus, some studies have concentrated on developing novel drugs to counteract inflammatory damage to cellular components, but the efficacy and adverse effects of current medicines remain major issues [3].
Isatin-containing heterocycles possess favorable anti-inflammatory properties [4,5]. SAR analyses of in silico studies have indicated that the hydrazide moiety provides a hydrogen bonding domain that enables the structure to form a hydrogen bond, which is essential for the interaction with amino acid residues, appending the potential to be a potent anti-inflammatory agent [6]. Various furan-containing compounds naturally occur in plants, oils, fruits, and marine foods [7]; are reported to be biologically active, having an anti-inflammatory effect [8,9]; and are found in a variety of pharmaceutical medicines, such as furosemide [10]. Here, we report the synthesis of 5-bromo-N′-(2-oxoindolin-3-ylidene)furan-2-carbohydrazide (1).

2. Results and Discussion

The synthesis of 5-bromo-N′-(2-oxoindolin-3-ylidene)furan-2-carbohydrazide (1) has been successfully achieved by condensation of commercially available isatin (2) with 5-bromofuran-2-carbohydrazide (3) under acidic conditions, as shown in Scheme 1. The reaction of isatin (2) and 5-bromofuran-2-carbohydrazide (3) took place for 15 min under reflux, with ethanol as the solvent and sulfuric acid as the catalyst. The expected product was filtered and washed using dichloromethane to isolate compound 1 as a yellowish solid with 79.4% yield.
Structure identification of the synthesized compound 1 using an NMR spectrometer resulted in an 1H NMR spectrum that corresponds to the structure of 5-bromo-N′-(2-oxoindolin-3-ylidene)furan-2-carbohydrazide (1). According to the 1H NMR spectrum, the proton of the NH group of the hydrazide moiety showed up as a broad singlet signal at δ 13.72 ppm. This NH group vibration was recorded at υ 3233 cm−1 in the FTIR spectrum. Meanwhile, the NH of the isatin ring was detected as a singlet signal at δ 11.30 ppm. In the 13C NMR spectrum, the signal of hydrazide carbonyl carbon was detected at δ 153.62 ppm. The C=O absorption reinforced this at υ 1620 cm−1 in the FTIR spectrum, while the signal of isatin carbonyl carbon was observed at δ 163.4 ppm. Furthermore, the absorption at υ 1680 cm−1 showed the absorption of the C=N group (imine), indicating the successful condensation of isatin (2) and 5-bromofuran-2-carbohydrazide (3). In the HRMS spectrum, since the bromine atom has two isotopes in nature, namely 79Br and 81Br, the [M+H]+ ions were recorded at m/z 333.9841 and 335.9813, which corresponds to the molecular formula for C13H879BrN3O3 and C13H881BrN3O3, respectively (calcd. 333.9822 (C13H879BrN3O3) and 335.9802 (C13H881BrN3O3)).

3. Materials and Methods

3.1. Materials

The materials utilized in this study were purchased from Tokyo Chemical Industry and Sigma-Aldrich and were not purified before use. Thin-layer chromatography (TLC) was used to monitor the reaction, which was seen under UV at 254 nm. The melting point was determined using Fisher-Johns melting point apparatus (Vernon Hills, IL, USA) and has not been corrected. The 1H and 13C NMR spectra were taken at 400 and 100 MHz on a Jeol JNM-ECS400 spectrometer (Tokyo, Japan) in DMSO-d6, with tetramethylsilane (TMS) serving as an internal standard. Reports are given in parts per million (ppm) for the chemical shifts (δ) and in Hertz for the coupling constants (J). The FTIR spectrum was captured using a Shimadzu 8400S FTIR spectrometer (Kyoto, Japan). Mass spectra were recorded in a Xevo G2-S Qtof mass spectrometer with an ESI ionization in positive mode. The absorbance of the sample was measured using a Thermo Scientific Genesys 10S UV-VIS spectrophotometer (Milford, CT, USA).

3.2. Synthesis of 5-Bromo-N’-(2-oxoindolin-3-ylidene)furan-2-carbohydrazide (1)

A solution of isatin (2) (0.074 g, 0.50 mmol), 5-bromofuran-2-carbohydrazide (3) (0.10 g, 0.49 mmol), and a drop of sulphuric acid in ethanol (10 mL) was refluxed for 15 min (the reaction was monitored by TLC using ethyl acetate as an eluent). The mixture was cooled to room temperature. The precipitate was filtered off, washed with dichloromethane, and dried to yield the title compound as a yellowish solid (130 mg, 79.4%%); mp: 212–213 °C; FTIR (KBr) υ (cm−1) 3233 (N-H), 1722 (C=O), 1680 (C=O), 1620 (C=N); 1H NMR (400 MHz, DMSO-d6) δ 6.91–6.96 (m, 2H, ArH), 7.06–7.11 (m, 1H, ArH), 7.35–7.44 (m, 2H, ArH), 7.59 (t, J = 7.6 Hz, 1H, ArH), 11.31 (1H, s, NH), 13.72 (1H, bs NH); 13C NMR (100 MHz, DMSO-d6) δ 111.7, 115.7, 119.9, 120.2, 121.6, 123.2, 127.3, 132.4, 138.9, 143.1, 148.1, 153.6, 163.4. HRESIMS m/z (pos): 333.9841 (C13H879BrN3O3) and 335.9813 (C13H881BrN3O3) (calcd. 333.9827 (C13H879BrN3O3) and 335.9807 (C13H881BrN3O3)) (Supplementary Materials).

Supplementary Materials

The following supporting information can be downloaded online. Figure S1: IR spectrum of compound 1; Figure S2: 1H NMR spectrum of compound 1; Figure S3: 13C NMR spectrum of 1; Figure S4: High-resolution mass spectrum of compound 1.

Author Contributions

Conceptualization, methodology, resources, funding acquisition: M.S. and S.N.; investigation, software, formal analysis, visualization, and writing—original draft preparation: N.P.A.; validation, data curation, writing—review and editing, supervision: M.S. and A.F. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Riset dan Inovasi untuk Indonesia Maju (RIIM) Batch 4 of the National Research and Innovation Agency (BRIN) and the Indonesia Endowment Fund for Education Agency (LPDP), grant numbers 161/IV/KS/11/2023 and 3183/PKS/ITS/2023.

Data Availability Statement

Data are contained within the article and Supplementary Materials.

Acknowledgments

The authors acknowledge the National Research and Innovation Agency and the Indonesia Endowment Fund for Education Agency for the funds.

Conflicts of Interest

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Chen, L.; Deng, H.; Cui, H.; Fang, J.; Zuo, Z.; Deng, J.; Li, Y.; Wang, X.; Zhao, L. Inflammatory Responses and Inflammation-Associated Diseases in Organs. Oncotarget 2017, 9, 7204–7218. [Google Scholar] [CrossRef] [PubMed]
  2. Hasan, M.M.; Islam, M.E.; Hossain, M.S.; Akter, M.; Rahman, M.A.A.; Kazi, M.; Khan, S.; Parvin, M.S. Unveiling the Therapeutic Potential: Evaluation of Anti-Inflammatory and Antineoplastic Activity of Magnolia champaca Linn’s Stem Bark Isolate through Molecular Docking Insights. Heliyon 2024, 10, e22972. [Google Scholar] [CrossRef] [PubMed]
  3. Rane, M.A.; Foster, J.G.; Wood, S.K.; Hebert, P.R.; Hennekens, C.H. Benefits and Risks of Nonsteroidal Anti-Inflammatory Drugs: Methodologic Limitations Lead to Clinical Uncertainties. Drug Inf. J. 2019, 53, 502–505. [Google Scholar] [CrossRef] [PubMed]
  4. Jarapula, R.; Gangarapu, K.; Manda, S.; Rekulapally, S. Synthesis, In Vivo Anti-Inflammatory Activity, and Molecular Docking Studies of New Isatin Derivatives. Int. J. Med. Chem. 2016, 2016, 2181027. [Google Scholar] [CrossRef] [PubMed]
  5. Hassanzadeh, F.; Jafari, E.; Khayambashi, N.; Hajhashemi, V. Synthesis and Anti-Inflammatory Effects Evaluation of 1,3 Substituted Isatin Derivatives:(TJPS-2020-0290.R1). TJPS 2021, 45, 248–252. [Google Scholar] [CrossRef]
  6. Cheke, R.S.; Patil, V.M.; Firke, S.D.; Ambhore, J.P.; Ansari, I.A.; Patel, H.M.; Shinde, S.D.; Pasupuleti, V.R.; Hassan, M.I.; Adnan, M.; et al. Therapeutic Outcomes of Isatin and Its Derivatives against Multiple Diseases: Recent Developments in Drug Discovery. Pharmaceuticals 2022, 15, 272. [Google Scholar] [CrossRef] [PubMed]
  7. Alizadeh, M.; Jalal, M.; Hamed, K.; Saber, A.; Kheirouri, S.; Pourteymour Fard Tabrizi, F.; Kamari, N. Recent Updates on Anti-Inflammatory and Antimicrobial Effects of Furan Natural Derivatives. J. Inflamm. Res. 2020, 13, 451–463. [Google Scholar] [CrossRef] [PubMed]
  8. Manolov, S.; Ivanov, I.; Bojilov, D.; Nedialkov, P. Synthesis, In Silico, and In Vitro Biological Evaluation of New Furan Hybrid Molecules. Processes 2022, 10, 1997. [Google Scholar] [CrossRef]
  9. Yang, L.; He, J. Traditional Uses, Phytochemistry, Pharmacology and Toxicological Aspects of the Genus Hosta (Liliaceae): A Comprehensive Review. J. Ethnopharmacol. 2021, 265, 113323. [Google Scholar] [CrossRef] [PubMed]
  10. Banerjee, R.; Kumar, H.K.S.; Banerjee, M. Medicinal Significance of Furan Derivatives: A Review. Int. J. Rev. Life. Sci. 2015, 5, 48–57. [Google Scholar]
Scheme 1. Synthesis of 5-bromo-N′-(2-oxoindolin-3-ylidene)furan-2-carbohydrazide (1).
Scheme 1. Synthesis of 5-bromo-N′-(2-oxoindolin-3-ylidene)furan-2-carbohydrazide (1).
Molbank 2024 m1941 sch001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Aijijiyah, N.P.; Fadlan, A.; Ningsih, S.; Santoso, M. 5-Bromo-N′-(2-oxoindolin-3-ylidene)furan-2-carbohydrazide. Molbank 2024, 2024, M1941. https://doi.org/10.3390/M1941

AMA Style

Aijijiyah NP, Fadlan A, Ningsih S, Santoso M. 5-Bromo-N′-(2-oxoindolin-3-ylidene)furan-2-carbohydrazide. Molbank. 2024; 2024(4):M1941. https://doi.org/10.3390/M1941

Chicago/Turabian Style

Aijijiyah, Nur Pasca, Arif Fadlan, Sri Ningsih, and Mardi Santoso. 2024. "5-Bromo-N′-(2-oxoindolin-3-ylidene)furan-2-carbohydrazide" Molbank 2024, no. 4: M1941. https://doi.org/10.3390/M1941

APA Style

Aijijiyah, N. P., Fadlan, A., Ningsih, S., & Santoso, M. (2024). 5-Bromo-N′-(2-oxoindolin-3-ylidene)furan-2-carbohydrazide. Molbank, 2024(4), M1941. https://doi.org/10.3390/M1941

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop